Moderna Omicron-Targeting Booster Candidates Demonstrate Superiority Over its Spikevax Booster
November 14th 2022Safety profile in this study showed the frequency of adverse reactions with these boosters were similar or lower than that of either a second or third dose of the original vaccine.
Read More
Wearing Masks Didn’t Increase Face Touching Among Kids in Simulated School Study
November 7th 2022The benefits to children of wearing face masks to prevent COVID-19 outweigh potential infectious risks from face touching, according to a study analyzing hand-to-face contact in a simulated school environment.
Read More
COVID-19 Vaccine Boosters: Roadblocks, the Future, and Communicating the Benefits to Patients
October 31st 2022“In the long run, what we will have is a virus that will become endemic in our population," said Donald J. Alcendor, MD. "The idea of thinking we can chase variants with boosters is a failed effort. We must realize that.”
Read More
Moderna’s Bivalent COVID-19 Booster Elicits Superior Antibody Responses
October 14th 2022Moderna’s new bivalent COVID-19 booster, which includes 25 micrograms each of messenger RNAs from the Wuhan-Hu-1 and Omicron B.1.1.529 variants of SARS-CoV-2, elicited antibody responses that were superior to those elicited by the original vaccine.
Read More
Increase in Enteroviruses Seen with Decreases in COVID-19 Precautions
October 13th 2022The Centers for Disease Control and Prevention (CDC) reports the rise in pediatric acute respiratory illnesses especially as there is a decrease in hygiene measures that were previously employed during the pandemic.
Read More